An E3 ubiquitin ligase: c-Cbl
Open Access
Abstract
BACKGROUND: Casitas B‐lineage lymphoma (Cbl) is an E3 ubiquitin ligase of many tyrosine kinase receptors. The authors previously detected c‐Cbl mutation and low protein expression in non‐small cell lung cancer (NSCLC). Therefore, it was hypothesized that overexpression of wild‐type c‐Cbl (c‐Cbl WT) exhibits tumor growth inhibition. METHODS: Wound healing and transwell assays were conducted to examine cell motility after c‐Cbl WT transfection in NSCLC cell lines. The cell cycle was investigated by flow cytometry. A549 and H1299‐Luc c‐Cbl WT‐transfected xenografts and experimental metastasis models were performed to investigate tumor growth and metastasis inhibition in vivo. RESULTS: Wound healing and transwell assays demonstrated inhibition of migration in the A549 and H226br cells 4 to 24 hours after transfection. Ectopic c‐Cbl WT expression was found to reduce cell proliferation at 48 hours in A549 cells. It is important to note that A549 and H1299‐Luc cells with ectopic c‐Cbl WT expression demonstrated inhibition of tumor growth in vivo. A549 cells overexpressing c‐Cbl WT inhibited tumor metastasis in animal models. CONCLUSIONS: To the best of the authors' knowledge, the current study is the first to demonstrate that c‐Cbl WT protein overexpression inhibits tumor metastasis and tumor growth in lung cancer xenograft models. These results provide evidence that ectopic expression of c‐Cbl WT protein can be potentially applied as targeted therapy for the treatment of lung cancer. Cancer 2011;. © 2011 American Cancer Society.Keywords
This publication has 13 references indexed in Scilit:
- Mutations of the TET2 and CBL genes: novel molecular markers in myeloid malignanciesAnnals of Hematology, 2010
- Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasmsNature, 2009
- Dual MET–EGFR combinatorial inhibition against T790M-EGFR-mediated erlotinib-resistant lung cancerBritish Journal of Cancer, 2008
- A Tale of Two Cbls: Interplay of c-Cbl and Cbl-b in Epidermal Growth Factor Receptor DownregulationMolecular and Cellular Biology, 2008
- Flt3-dependent transformation by inactivating c-Cbl mutations in AMLBlood, 2007
- Defective ubiquitinylation of EGFR mutants of lung cancer confers prolonged signalingOncogene, 2007
- The Cbl family proteins: Ring leaders in regulation of cell signalingJournal of Cellular Physiology, 2006
- A Novel Consensus Motif in Fibronectin Mediates Dipeptidyl Peptidase IV Adhesion and MetastasisJournal of Biological Chemistry, 2003
- Mutation of the c-Cbl TKB Domain Binding Site on the Met Receptor Tyrosine Kinase Converts It into a Transforming ProteinMolecular Cell, 2001
- The Tyrosine Kinase Negative Regulator c-Cbl as a RING-Type, E2-Dependent Ubiquitin-Protein LigaseScience, 1999